Citigroup’s Intermolecular, Inc. IMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-9
Closed 7643
2016
Q1
$0 Buy
+9
New +$20 ﹤0.01% 7952
2014
Q4
Sell
-9,001
Closed -$21K 7446
2014
Q3
$21K Sell
9,001
-1,070
-11% -$2.45K ﹤0.01% 5895
2014
Q2
$23K Buy
10,071
+7,406
+278% +$18.5K ﹤0.01% 5740
2014
Q1
$7K Sell
2,665
-2,757
-51% -$10K ﹤0.01% 6499
2013
Q4
$27K Buy
5,422
+5,398
+22,492% +$30.5K ﹤0.01% 6051
2013
Q3
$0 Sell
24
-54
-69% -$339 ﹤0.01% 7089
2013
Q2
$0 Buy
+78
New +$664 ﹤0.01% 6830

Other funds holding IMI

Citigroup's IMI Position: Q2 2016 in Review

Citigroup sold out of Intermolecular, Inc. (IMI) in Q2 2016, closing a stake of 9 shares.

Citigroup first reported a position in IMI in Q2 2013 and held it in 7 quarters. The position peaked at $27K in Q4 2013. 34 funds tracked by Wall St. Rank hold IMI as of Q2 2016.

  • Citigroup reported no remaining Intermolecular, Inc. position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 9 Intermolecular, Inc. shares in Q2 2016.
  • Citigroup first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 7 quarters.
  • Citigroup's Intermolecular, Inc. position peaked at $27K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.